Skip to main content
INNOVATE Corp. logo

INNOVATE Corp. — Investor Relations & Filings

Ticker · VATE ISIN · US45784J1051 LEI · 549300S6O246JWQQ1K58 US Financial and insurance activities
Filings indexed 1,196 across all filing types
Latest filing 2014-06-07 Director's Dealing
Country US United States of America
Listing US VATE

About INNOVATE Corp.

https://innovatecorp.com/

INNOVATE Corp. is a diversified holding company that acquires and manages a portfolio of assets across three primary sectors: Infrastructure, Life Sciences, and Spectrum. The Infrastructure segment, through its subsidiary DBM Global, is a provider of structural steel and industrial construction services. The Life Sciences portfolio focuses on developing innovative healthcare technologies and includes companies such as Pansend Life Sciences, R2 Technologies, which markets an aesthetic dermatology device, and MediBeacon, which has developed a system for assessing kidney function. The Spectrum segment operates through HC2 Broadcasting, a large group of broadcast television stations.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2014-06-07 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-06-05 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes a Securities Purchase Agreement, detailing a private placement financing transaction including issuance of preferred and common stock, terms of the preferred stock, dividend rights, conversion rights, redemption rights, and board rights. This is a clear update on the company's capital raising and financing activities. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is not a proxy, voting result, or management change announcement. The detailed description of the securities purchase and terms aligns with a Capital/Financing Update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2014-06-04 English
Director's Dealing 2014
Director's Dealing
2014-05-30 English
Director's Dealing 2014
Director's Dealing
2014-05-23 English
Director's Dealing 2014
Director's Dealing
2014-05-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.